Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?. Issue 3 (26th March 2021)
- Record Type:
- Journal Article
- Title:
- Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?. Issue 3 (26th March 2021)
- Main Title:
- Lymph Node Tumor Burden Correlates With Tumor Budding and Poorly Differentiated Clusters: A New Prognostic Factor in Colorectal Carcinoma?
- Authors:
- Archilla, Ivan
Díaz-Mercedes, Sherley
Aguirre, José Javier
Tarragona, Jordi
Machado, Isidro
Rodrigo, Maria Teresa
Lopez-Prades, Sandra
Gorostiaga, Iñigo
Landolfi, Stefania
Alén, Begoña Otero
Balaguer, Francesc
Castells, Antoni
Camps, Jordi
Cuatrecasas, Miriam - Abstract:
- Abstract : INTRODUCTION: Molecular lymph node (LN) staging in early colorectal cancer (CRC) has demonstrated to be more precise than conventional histopathology pN staging. Tumor budding (TB) and poorly differentiated clusters (PDCs) are associated with LN metastases, recurrences, and lower survival in CRC. We evaluated the correlation between the total tumor load (TTL) in LNs from CRC surgical specimens with patient outcome, TB, and PDC. METHODS: In this retrospective multicentre study, 5, 931 LNs from 342 stage I–III CRC were analyzed by both hematoxylin and eosin and molecular detection of tumor cytokeratin 19 mRNA by one-step nucleic acid amplification. TB and PDC were evaluated by hematoxylin and eosin and cytokeratin 19 immunohistochemistry. Results: One-step nucleic acid was positive in 38.3% patients (n = 131). Tumor Budding was low in 45% cases, intermediate in 25%, and high in 30%. Poorly Differentiated Clusters were low-grade G1 in 53%, G2 in 32%, and G3 in 15%. TB and PDC correlated with TTL, high-grade, lymphovascular and perineural invasion, pT, pN and stage ( P < 0.001). TB, PDC, and TTL ≥ 6, 000 copies/µL were associated with worse overall survival ( P = 0.002, P = 0.013, and P = 0.046) and disease-free survival ( P < 0.001). Discussion: The implementation of more sensitive molecular methods to assess LN status is a promising alternative approach to pN staging, which could be integrated to other factors to help risk stratification and management of patientsAbstract : INTRODUCTION: Molecular lymph node (LN) staging in early colorectal cancer (CRC) has demonstrated to be more precise than conventional histopathology pN staging. Tumor budding (TB) and poorly differentiated clusters (PDCs) are associated with LN metastases, recurrences, and lower survival in CRC. We evaluated the correlation between the total tumor load (TTL) in LNs from CRC surgical specimens with patient outcome, TB, and PDC. METHODS: In this retrospective multicentre study, 5, 931 LNs from 342 stage I–III CRC were analyzed by both hematoxylin and eosin and molecular detection of tumor cytokeratin 19 mRNA by one-step nucleic acid amplification. TB and PDC were evaluated by hematoxylin and eosin and cytokeratin 19 immunohistochemistry. Results: One-step nucleic acid was positive in 38.3% patients (n = 131). Tumor Budding was low in 45% cases, intermediate in 25%, and high in 30%. Poorly Differentiated Clusters were low-grade G1 in 53%, G2 in 32%, and G3 in 15%. TB and PDC correlated with TTL, high-grade, lymphovascular and perineural invasion, pT, pN and stage ( P < 0.001). TB, PDC, and TTL ≥ 6, 000 copies/µL were associated with worse overall survival ( P = 0.002, P = 0.013, and P = 0.046) and disease-free survival ( P < 0.001). Discussion: The implementation of more sensitive molecular methods to assess LN status is a promising alternative approach to pN staging, which could be integrated to other factors to help risk stratification and management of patients with early-stage CRC. This study demonstrates the correlation of the amount of LN tumor burden with TB and PDCs. TTL is related to the outcome and could be used as a new prognostic factor in CRC (see Visual Abstract, Supplementary Digital Content 2, http://links.lww.com/CTG/A512 ). … (more)
- Is Part Of:
- Clinical and translational gastroenterology. Volume 12:Issue 3(2021)
- Journal:
- Clinical and translational gastroenterology
- Issue:
- Volume 12:Issue 3(2021)
- Issue Display:
- Volume 12, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 12
- Issue:
- 3
- Issue Sort Value:
- 2021-0012-0003-0000
- Page Start:
- e00303
- Page End:
- Publication Date:
- 2021-03-26
- Subjects:
- Stomach -- Diseases -- Periodicals
Intestines -- Diseases -- Periodicals
Gastroenterology
Gastrointestinal Diseases
Liver Diseases
Intestines -- Diseases
Stomach -- Diseases
Periodical
Periodicals
Fulltext
Internet Resources
Periodicals
Electronic journals
616.33 - Journal URLs:
- http://bibpurl.oclc.org/web/52768 ↗
http://www.nature.com/ctg ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1564/ ↗
https://journals.lww.com/ctg/pages/default.aspx ↗
http://www.nature.com/ ↗ - DOI:
- 10.14309/ctg.0000000000000303 ↗
- Languages:
- English
- ISSNs:
- 2155-384X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24079.xml